Business Context and Reporting Period
This Form 6-K filing by MDxHealth SA covers the month of March 2023. The filing serves to furnish press releases issued on March 2, March 6, and March 8, 2023, and to announce the posting of financial results for the period ended December 31, 2022. Additionally, the Company amended its Articles of Association on March 8, 2023, to reflect a capital increase.
Key Financial Metrics
The filing text references the posting of 2022 financial results as of December 31, 2022 (Exhibit 99.5) but does not contain the specific numerical data within the body of this report. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this text.
Material Changes
- Capital Increase: The Company amended its Articles of Association to account for the issuance of 7,500,000 new shares.
- Corporate Communications: Four press releases were issued between March 2 and March 8, 2023, detailing material events.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, or a detailed discussion of risks and contingencies within the main text. Such information is contained in the attached exhibits (Press Releases and 2022 Financial Results), which are furnished but not deemed "filed" for the purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.5 for the specific financial performance metrics for the year ended December 31, 2022.
- Examine Exhibits 99.1 through 99.4 to understand the context of the press releases issued in early March 2023.
- Verify the impact of the 7,500,000 new shares on existing shareholder dilution and capital structure.
- Confirm the legal status of the amended Articles of Association (Exhibit 3.1).